Search This Blog

Friday, March 3, 2023

Neurocrine upped to Outperform from In Line by Evercore

 Target $130

https://finviz.com/quote.ashx?t=NBIX&p=d

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.